Vanda Pharmaceuticals (VNDA) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.04% |
| Dec 31, 2025 | -40.52% |
| Sep 30, 2025 | -40.01% |
| Jun 30, 2025 | -38.77% |
| Mar 31, 2025 | -100.14% |
| Dec 31, 2024 | -25.54% |
| Sep 30, 2024 | -20.20% |
| Jun 30, 2024 | -19.90% |
| Mar 31, 2024 | -50.60% |
| Dec 31, 2023 | -16.66% |
| Sep 30, 2023 | -15.06% |
| Jun 30, 2023 | -11.23% |
| Mar 31, 2023 | 12.53% |
| Dec 31, 2022 | 49.59% |
| Sep 30, 2022 | 26.24% |
| Jun 30, 2022 | 34.99% |
| Mar 31, 2022 | 0.16% |
| Dec 31, 2021 | 80.61% |
| Sep 30, 2021 | 93.22% |
| Jun 30, 2021 | 36.45% |
| Mar 31, 2021 | 23.25% |
| Dec 31, 2020 | 22.28% |
| Sep 30, 2020 | 23.56% |
| Jun 30, 2020 | 32.16% |
| Mar 31, 2020 | 16.22% |
| Dec 31, 2019 | -39.16% |
| Sep 30, 2019 | 59.98% |
| Jun 30, 2019 | 20.45% |
| Mar 31, 2019 | 53.10% |
| Dec 31, 2018 | 27.38% |
| Sep 30, 2018 | 27.35% |
| Jun 30, 2018 | 27.65% |
| Mar 31, 2018 | 21.78% |
| Dec 31, 2017 | -15.84% |
| Sep 30, 2017 | 3.20% |
| Jun 30, 2017 | 28.21% |
| Mar 31, 2017 | 0.86% |
| Dec 31, 2016 | 38.77% |
| Sep 30, 2016 | 33.01% |
| Jun 30, 2016 | -27.11% |
| Mar 31, 2016 | -145.42% |
| Dec 31, 2015 | -78.19% |
| Sep 30, 2015 | -66.02% |
| Jun 30, 2015 | -44.92% |